Qureshi Jehanzeb MD is categorized under Internal Medicine Doctors in Waynesboro, PA and active since 2006.
Qureshi Jehanzeb MD was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jehanzeb Qureshi at the company’s single location by writing to 12104 Buchanan Trail East, Waynesboro, Pennsylvania PA 17268 or by phoning (717) 749-0150. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Qureshi Jehanzeb MD |
| Contact Person: | Jehanzeb Qureshi |
| Address: | 12104 Buchanan Trail East, Waynesboro, Pennsylvania 17268 |
| Phone Number: | (717) 749-0150 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Qureshi Jehanzeb MD was started in 2006 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jehanzeb Qureshi for inquiries that concern Qureshi Jehanzeb MD by calling the company number (717) 749-0150, as your correspondence is most welcome. Additionally, the physical location of the single location of Qureshi Jehanzeb MD can be found at the coordinates 39.73813,-77.52822 as well as the street address 12104 Buchanan Trail East in Waynesboro, Pennsylvania 17268.
For its online presence, you may visit Qureshi Jehanzeb MD’s website at and engage with its social media outlets through on Twitter and on Facebook.